Axsome Therapeutics, Inc.AXSMNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P17
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -2.03% |
| 2024 | 91.00% |
| 2023 | 69.02% |
| 2022 | -0.20% |
| 2021 | -17.34% |
| 2020 | 30.94% |
| 2019 | 128.33% |
| 2018 | 17.72% |
| 2017 | -5.86% |
| 2016 | 212.82% |